Imidazole propionate: a novel driver of atherosclerosis and biomarker of subclinical diseases

Cardiovascular disease remains the leading cause of death worldwide, but its pathogenesis is not yet fully understood, hampering the development of effective early diagnostics and treatments. Despite regular treatments that target traditional risk factors such as cholesterol levels, many patients face cardiovascular events. Emerging evidence suggests that chronic inflammation and the gut microbiome contribute to […]